FURESTEM-AD Inj.
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for FURESTEM-AD Inj., covering 2016-10-06 to 2022-01-11. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Explore the Efficacy of Multiple Doses of FURESTEM-AD Inj. for Moderate to Severe Chronic Atopic Dermatitis [Phase 1, Phase 2]